Matthew Womack

Matthew Womack has extensive experience in the field of clinical development and medical affairs. Matthew is currently the Director of Clinical Development at Endomag since November 2018. Prior to that, they worked at Firstkind Limited as the Head of Clinical Affairs from August 2014 to November 2018 and as the Clinical Program Manager from March 2013 to August 2014. Before joining Firstkind Limited, Matthew held various positions at ORTEQ Sports Medicine, including Head of Global Medical Affairs from February 2012 to March 2013, Senior Manager Medical Affairs from December 2010 to January 2012, and Manager Medical Affairs from November 2009 to December 2010. Matthew also worked as a Medical Scientific Advisor at UCB Pharma from June 2009 to December 2009, and as a UK Clinical Projects Co-Ordinator at Chiesi from June 2008 to June 2009. Earlier in their career, they gained experience as a Clinical research associate at Depuy International from July 2007 to June 2008. Matthew started their career as a Postdoctoral research scientist at the University of Liverpool from June 2004 to June 2007.

Matthew Womack pursued their education with dedication and achieved impressive academic milestones. From 1996 to 2000, they attended the University of Bradford, where they obtained a Bachelor of Science degree (with honors) in Biomedical Sciences. Following this, from 2000 to 2004, Matthew furthered their education at the same university and earned a doctoral degree (PhD) in Neuropharmacology. Matthew'seducational journey showcases their passion for understanding the intricate field of neuroscience and pharmacology.